• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

Centogene

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · February 8, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, …

News · February 1, 2022

CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board

centogene

Nomination adds significant expertise to support pharma partnerships and an impressive track record in value creation CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE …

News · February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

centogene

Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and …

News · February 1, 2022

CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer

centogene

Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene …

News · October 8, 2021

CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

centogene

Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare Diseases Around the World CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and SOUTH …

News · October 22, 2020

CENTOGENE Announces Leadership Transition

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world …

News · July 15, 2020

CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases …

News · July 10, 2020

CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares

centogene

July 7, 2020 at 6:16 PM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases …

News · April 8, 2020

Centogene öffnet seine Labore für Coronatests

centogene

Verantwortung in Krisenzeiten: Ein Rostocker Unternehmen, das sonst seltenen Krankheiten auf der Spur ist, öffnet seine Labore für lebensrettende Coronatests. Bis zu 10.000 Abstriche können pro Tag …

News · March 24, 2020

Centogene Announces Commencement of Testing for COVID-19

centogene

Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (GLOBAL NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical …

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact